Sign in Register

Drug class

Chloroquines

The term "chloroquines" is an informal grouping rather than an official pharmacologic class name, representing 4-aminoquinoline antimalarials and disease-modifying antirheumatic agents such as chloroquine and hydroxychloroquine. Read more about Chloroquines

36 drugs in this class 30 manufacturers

Related classes & indications

Antimalarial DrugsAnti-infectives · 223 prescription drugs Antiprotozoal AgentsAnti-infectives · 102 prescription drugs Malaria PreventionTop indication · 180 prescription drugs

Showing 10–18 of 36 drugs

Sort

HYDROXYCHLOROQUINE SULFATE

ANTIRHEUMATIC AGENTS (DMARDS, NON-BIOLOGIC) · PLASMODIUM FALCIPARUM MALARIA ·+11

Amneal Pharmaceuticals

HYDROXYCHLOROQUINE SULFATE

ANTIRHEUMATIC AGENTS (DMARDS, NON-BIOLOGIC) · PLASMODIUM FALCIPARUM MALARIA ·+11

SUN PHARMACEUTI

SOVUNA (hydroxychloroquine sulfate)

ANTIRHEUMATIC AGENTS (DMARDS, NON-BIOLOGIC) · PLASMODIUM FALCIPARUM MALARIA ·+11

ANI PHARMACEUTI

HYDROXYCHLOROQUINE SULFATE

ANTIRHEUMATIC AGENTS (DMARDS, NON-BIOLOGIC) · PLASMODIUM FALCIPARUM MALARIA ·+11

BLENHEIM PHARMA

HYDROXYCHLOROQUINE SULFATE

ANTIRHEUMATIC AGENTS (DMARDS, NON-BIOLOGIC) · PLASMODIUM FALCIPARUM MALARIA ·+11

ACCORD HEALTHCA

CHLOROQUINE PHOSPHATE

ANTIRHEUMATIC AGENTS (DMARDS, NON-BIOLOGIC) · PLASMODIUM FALCIPARUM MALARIA ·+4

AVKARE

HYDROXYCHLOROQUINE SULFATE

ANTIRHEUMATIC AGENTS (DMARDS, NON-BIOLOGIC) · PLASMODIUM FALCIPARUM MALARIA ·+11

AVPAK

HYDROXYCHLOROQUINE SULFATE

ANTIRHEUMATIC AGENTS (DMARDS, NON-BIOLOGIC) · PLASMODIUM FALCIPARUM MALARIA ·+11

A-S MEDICATION

HYDROXYCHLOROQUINE SULFATE

ANTIRHEUMATIC AGENTS (DMARDS, NON-BIOLOGIC) · PLASMODIUM FALCIPARUM MALARIA ·+11

DIRECT RX

Filter & compare in the drug finder → Opens the drug finder with Chloroquines preselected. Add indication or manufacturer filters there.

About Chloroquines.

The term "chloroquines" is an informal grouping rather than an official pharmacologic class name, representing 4-aminoquinoline antimalarials and disease-modifying antirheumatic agents such as chloroquine and hydroxychloroquine.

In infectious disease, these medications inhibit the biocrystallization of toxic heme within intraerythrocytic malaria parasites, thereby killing sensitive *Plasmodium* species.

In rheumatology, they exert immunomodulatory and anti-inflammatory effects by accumulating in acidic lysosomes, which impairs antigen presentation and suppresses toll-like receptor activation.

Clinically, these agents are primarily indicated for the prevention and treatment of malaria, as well as the long-term management of autoimmune disorders including systemic lupus erythematosus and rheumatoid arthritis.

fda.gov
The term "chloroquines" is an informal grouping rather than an official pharmacologic class name, representing 4-aminoquinoline antimalarials and disease-modifying antirheumatic agents such as chloroquine and hydroxychloroquine
fda.gov
The term "chloroquines" is an informal grouping rather than an official pharmacologic class name, representing 4-aminoquinoline antimalarials and disease-modifying antirheumatic agents such as chloroquine and hydroxychloroquine
nih.gov
The term "chloroquines" is an informal grouping rather than an official pharmacologic class name, representing 4-aminoquinoline antimalarials and disease-modifying antirheumatic agents such as chloroquine and hydroxychloroquine
nih.gov
The term "chloroquines" is an informal grouping rather than an official pharmacologic class name, representing 4-aminoquinoline antimalarials and disease-modifying antirheumatic agents such as chloroquine and hydroxychloroquine In infectious disease, these medications inhibit the biocrystallization of toxic heme within intraerythrocytic malaria parasites, thereby killing sensitive *Plasmodium* species In rheumatology, they exert immunomodulatory and anti-inflammatory effects by accumulating in a...
nih.gov
In infectious disease, these medications inhibit the biocrystallization of toxic heme within intraerythrocytic malaria parasites, thereby killing sensitive *Plasmodium* species
fda.gov
In rheumatology, they exert immunomodulatory and anti-inflammatory effects by accumulating in acidic lysosomes, which impairs antigen presentation and suppresses toll-like receptor activation Clinically, these agents are primarily indicated for the prevention and treatment of malaria, as well as the long-term management of autoimmune disorders including systemic lupus erythematosus and rheumatoid arthritis